0JDK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Iovance Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 9.68 USD -33.92% Market Closed

Market Cap: $129.9B

I	Iovance Biotherapeutics Inc LSE:0JDK	US
S	Stagwell Inc F:6IY	US
	First Tellurium Corp OTC:FSTTF	CA
H	Healthy Choice Wellness Corp AMEX:HCWC	US
E	Essilorluxottica SA XHAN:ESL	FR
	Menon Bearings Ltd BSE:523828	IN
B	BSL Ltd BSE:514045	IN
C	Charles Schwab Corp XMUN:SWG	US

Profitability Summary

Iovance Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Negative 3Y Average Gross Margin

-134%

Gross Margin is Increasing

-800% > 48%

Negative Operating Margin

-93%

Negative 3Y Average Operating Margin

-6 022%

Operating Margin is Increasing

-62 866% > -93%

Negative Net Margin

-89%

Negative 3Y Average Net Margin

-5 800%

Net Margin is Increasing

-60 983% > -89%

Negative Free Cash Flow Margin

-91%

Negative 3Y Average Free Cash Flow Margin

-5 106%

Free Cash Flow Margin is Increasing

-53 142% > -91%

Negative ROE

-40%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-85%

ROIC is Increasing

-140% > -51%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.